Novo Nordisk Q1 2023 Investor Presentation

Novo Nordisk's Q1 2023 investor presentation covering strategic aspirations, financial results, innovation pipeline, and commercial execution. The Danish focused healthcare company discusses progress across diabetes, obesity, and other therapeutic areas with updates on products including Victoza, Ozempic, Saxenda, and Wegovy.